Topics
plasma cell leukemiaDisease
myelomaDisease
Plasma cells are occasionally observed in the peripheral blood of the patients with multiple myeloma. When the number of these circulating cells is significant, the term of plasma cell leukemia is used. We report 5 cases of plasma cell leukemia with poor prognosis with review of the literature
Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma characterized by the presence...
Plasma cell leukemia (PCL) is a rare presentation of multiple myeloma characterized by the presence ...
Plasma cell leukemia (PCL) is a rare (1-2 %) aggressive plasma cell dyscrasia (PCD) with a poor prog...
Plasma cells are occasionally observed in the peripheral blood of the patients with multiple myeloma...
Abstract Primary plasma cell leukemia (PCL) has a consistently ominous prognosis, even after progres...
The presence of circulating plasma cells in patients with multiple myeloma is considered a marker fo...
The presence of circulating plasma cells in patients with multiple myeloma is considered a marker fo...
Plasma cell leukaemia is an extremely rare haematological malignancy with a poor prognosis. It is d...
Plasma cell leukemia (PCL) is a rare lymphoproliferative disorder characterized by monoclonal prolif...
Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma accounting for 2-3% of all pl...
Primary plasma cell leukemia (PCL) is a rare plasma cell disorder, and current knowledge regarding s...
Epidemiological and clinical information on primary plasma cell leukemia (pPCL) are rarely reported....
Epidemiological and clinical information on primary plasma cell leukemia (pPCL) are rarely reported....
Plasma cell leukemia (PCL) is a rare hematologic malignancy with very poor outcome. It is defined by...
Plasma cell leukemia (PCL) is a rare and aggressive variant of plasma cell dyscrasias that can occur...
Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma characterized by the presence...
Plasma cell leukemia (PCL) is a rare presentation of multiple myeloma characterized by the presence ...
Plasma cell leukemia (PCL) is a rare (1-2 %) aggressive plasma cell dyscrasia (PCD) with a poor prog...
Plasma cells are occasionally observed in the peripheral blood of the patients with multiple myeloma...
Abstract Primary plasma cell leukemia (PCL) has a consistently ominous prognosis, even after progres...
The presence of circulating plasma cells in patients with multiple myeloma is considered a marker fo...
The presence of circulating plasma cells in patients with multiple myeloma is considered a marker fo...
Plasma cell leukaemia is an extremely rare haematological malignancy with a poor prognosis. It is d...
Plasma cell leukemia (PCL) is a rare lymphoproliferative disorder characterized by monoclonal prolif...
Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma accounting for 2-3% of all pl...
Primary plasma cell leukemia (PCL) is a rare plasma cell disorder, and current knowledge regarding s...
Epidemiological and clinical information on primary plasma cell leukemia (pPCL) are rarely reported....
Epidemiological and clinical information on primary plasma cell leukemia (pPCL) are rarely reported....
Plasma cell leukemia (PCL) is a rare hematologic malignancy with very poor outcome. It is defined by...
Plasma cell leukemia (PCL) is a rare and aggressive variant of plasma cell dyscrasias that can occur...
Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma characterized by the presence...
Plasma cell leukemia (PCL) is a rare presentation of multiple myeloma characterized by the presence ...
Plasma cell leukemia (PCL) is a rare (1-2 %) aggressive plasma cell dyscrasia (PCD) with a poor prog...
Add to ORKG